About Teyro Labs
Teyro Labs is a Healthcare company. Development and manufacturing of generic pharmaceutical formulations and active ingredients in India. The company has 175 employees. Its Indian entity Teyro Labs Private Limited reported revenue of ₹15.00 Cr. Teyro Labs offers products and services including Finished Dosage Formulations and Active Pharmaceutical Ingredients. Its focus areas include Pharmaceuticals, Active Pharmaceutical Ingredients, Manufacturing and Generic Drugs.
Company details
Teyro Labs is headquartered in Chennai, India, and is identified as a generic pharmaceutical company that engages in the research, development, and manufacturing of IP-led niche finished dosage formulations and active pharmaceutical ingredients. Contract manufacturing for sterile and non-sterile products, including oncology and hormones, is conducted at advanced facilities with aseptic processing capabilities. Stability testing and analytical method development are also performed to meet international standards, with operations extending across global markets. USFDA registration is held by the company to ensure compliance in highly regulated environments.
- Employees 175
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn
- Legal Name Teyro Labs Private Limited
- Date of Incorporation 21 Feb, 2014
- Jurisdiction Chennai, Tamil Nadu, India
- Indian entity revenue₹15.00 Cr
FY 2024 · +498% YoY
- Indian entity net loss-₹23.11 Cr
FY 2024 · -154% margin
- Indian entity EBITDA₹30.02 Cr
FY 2024 · 200% margin
- Employee Count175
Associated legal entities of Teyro Labs
Teyro Labs operates through Teyro Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Teyro Labs Private Limited CIN U24100TN2014PTC095150 | Active | 21 Feb 2014 | Chennai, Tamil Nadu | ₹15.0 Cr | 175 | 2 | View details |
Products & Services of Teyro Labs
Teyro Labs offers a comprehensive portfolio of products and services, including Finished Dosage Formulations and Active Pharmaceutical Ingredients.
Development and manufacture of niche formulations for oncology and hormones are carried out by Teyro Labs.
Production of active pharmaceutical ingredients for various applications is handled by Teyro Labs.
Board of directors of Teyro Labs Private Limited (Teyro Labs)
Teyro Labs Private Limited is the primary company behind Teyro Labs. The board of Teyro Labs Private Limited currently have 2 directors; the longest-serving is Sundeep Anand Jegathrakshagan, appointed in 2014. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sundeep Anand Jegathrakshagan DIN 01728742 | Director | 01 Dec 2014 | 11 yrs 10 mo | Teyro Labs Private Limited |
| Jagathrakshakan Swamikannu DIN 01720227 | Director | 18 Aug 2023 | 3 yrs 2 mo | Teyro Labs Private Limited |
Financials of Teyro Labs
Figures of Teyro Labs Private Limited, the primary company behind Teyro Labs, for FY 2024. Revenue was ₹15.00 Cr (+498% year on year). Net loss was -₹23.11 Cr (-154% margin). EBITDA was ₹30.02 Cr (200% margin). Revenue has grown at a compounded annual rate of -6% over three years and +100% over five years.
- ₹15.00 CrRevenue · FY 2024 · +498% YoY
- -₹23.11 CrNet loss · -154% margin
- ₹30.02 CrEBITDA · 200% margin
- ₹36.65 CrPaid-up capital
- 175Employees (provident fund records)
- -6%Revenue CAGR, 3 years
- +100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Teyro Labs Private Limited are on its company page.
Detailed financial statements for Teyro Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Teyro Labs
Complete news archive for Teyro Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Teyro Labs
Teyro Labs has 175 employees.
The primary company behind Teyro Labs, Teyro Labs Private Limited, reported revenue of ₹15.00 Cr for FY 2024, up 498% year on year.
Teyro Labs is headquartered in Chennai, India, and is identified as a generic pharmaceutical company that engages in the research, development, and manufacturing of IP-led niche finished dosage formulations and active pharmaceutical ingredients. Contract manufacturing for sterile and non-sterile products, including oncology and hormones, is conducted at advanced facilities with aseptic processing capabilities. Stability testing and analytical method development are also performed to meet international standards, with operations extending across global markets. USFDA registration is held by the company to ensure compliance in highly regulated environments.
Teyro Labs offers Finished Dosage Formulations and Active Pharmaceutical Ingredients.
Teyro Labs operates through Teyro Labs Private Limited.
The legal entities of Teyro Labs currently have 2 directors, including Jagathrakshakan Swamikannu, Sundeep Anand Jegathrakshagan.